This is a recent post on the PSP eReport:
AAFPRS: Botox Is Safe for Cosmetic Procedures
In response to the recent news of the FDA’s safety review of botulinum toxins in the United States, the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) wants to clarify something: the FDA’s inquiry relates primarily to high-dose medical uses of botulinum toxin Type A and not its aesthetic uses.
Botulinum toxin Type A is indicated and used to treat a variety of often serious medical conditions, in which the drug does not have FDA approval. On the other hand, the FDA has for 6 years approved the drug’s use the aesthetic treatment of wrinkles between the brows and involves very different doses. the organization stated this week.
On February 8, the FDA announced it was reviewing certain serious adverse events following the use of botulinum toxins, particularly for the management of juvenile cerebral palsy.
The AAFPRS further clarified that the adverse side effects under investigation by the FDA occurred in children with cerebral palsy where the therapeutic benefit of using botulinum toxin Type A was achieved in doses that were 15 to 20 times the dose used for aesthetic purposes.